Interleukin 6 Inhibition With Vamikibart for Uveitic Macular Edema: The Phase 1 DOVETAIL Nonrandomized - Quiz - MDSpire

Interleukin 6 Inhibition With Vamikibart for Uveitic Macular Edema: The Phase 1 DOVETAIL Nonrandomized

  • By

  • Sumit Sharma

  • Phoebe Lin

  • Allen Hu

  • Eric B. Suhler

  • Meike Pauly-Evers

  • William Holmes

  • Zeinab Barekati

  • Daniela Willen

  • Lachlan Macgregor

  • Laura Steeples

  • Zdenka Haskova

  • Derrick Feenstra

  • David Silverman

  • Benedicte Passemard

  • Sascha Fauser

  • Marina Mesquida

  • May 1, 2026

  • 0 min

Share

Original Source(s)

Interleukin 6 Inhibition With Vamikibart for Uveitic Macular Edema: The Phase 1 DOVETAIL Nonrandomized

  • by Sumit Sharma, Phoebe Lin, Allen Hu, Eric B. Suhler, Meike Pauly-Evers, William Holmes, Zeinab Barekati, Daniela Willen, Lachlan Macgregor, Laura Steeples, Zdenka Haskova, Derrick Feenstra, David Silverman, Benedicte Passemard, Sascha Fauser, Marina Mesquida

  • May 1, 2026

Related Content

Treatment Strategies in Endogenous Fungal Endophthalmitis

Management of endogenous fungal endophthalmitis is complex, with wide variation in treatment strategies. Systemic markers of disease appear to influence the choice of initial therapy more than ocular findings. Although no definitive evidence favors IV over oral systemic therapy, a comprehensive, multidisciplinary approach that considers ocular involvement is essential to optimize patient outcomes in EFE.

Cell death in uveitis: pyroptosis, ferroptosis, apoptosis, and beyond

Revealing Neurosarcoidosis in a Patient with Acute Zonal Occult Outer Retinopathy: A Case Study